CoChat

Evaluation of neuroprotective and anti-amnesic effects of Elaeagnus umbellata Thunb. On scopolamine-induced memory impairment in mice

Open access
Nazir, Nausheen, Zahoor, Muhammad, Nisar, Mohammad, Karim, Nasiara, Latif, Abdul, Ahmad, Sajjad, Uddin, Zia · 2020 · BMC Complementary Medicine and Therapies

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Background: Elaeagnus umbellata is abundantly found in Himalayan regions of Pakistan which is traditionally used to treat various health disorders. However, the experimental evidence supporting the anti-amnesic effect is limited. Therefore the study was aimed to evaluate the prospective beneficial effect of E. umbellata on learning and memory in mice. Objectives: To assess neuroprotective and anti-amnesic effects of E. umbellata fruit extracts and isolated compounds on the central nervous system. Methods: Major phytochemical groups present in methanolic extract of E. umbellata were qualitatively determined. The total phenolic and flavonoid contents were also determined in extract/fractions of E. umbellata. On the basis of in vitro promising anticholinesterases (AChE & BChE) and antioxidant activities observed for CHF. Ext and isolated compound-I (Chlorogenic acid = CGA), they were further evaluated for learning and memory in normal and scopolamine-induced cognitive impairment in mice using memory behavioral tests such as the Y maze and Novel object recognition using standard procedures. The test sample were further assessed for in vivo anticholinesterases (AChE & BChE) and DPPH free radical scavenging activities in mice brain sample and finally validated by molecular docking study using GOLD software. Results: The extract/fractions and isolated compounds were tested for their anticholinesterase and antioxidant potentials. The CHF. Ext and CGA showed maximum % inhibition of tested cholinesterases and free radicals. The CHF. Ext and CGA reversed the effects of scopolamine in mice. The CHF. Ext and CGA significantly increased the alternate arm returns and % spontaneous alteration performance while escape latency times (second) significantly decreased in Y maze test. The CHF. Ext and CGA significantly increased the time spent with novel object and also increased the discrimination index in the Novel object recognition test. Furthermore, molecular docking was used to validate the mechanism of cholinesterases inhibition of isolated compounds. Conclusion: The data obtained from behavioral and biochemical studies (AChE/BChE and DPPH/ABTS inhibition) have shown that E. umbellata possessed significant memory enhancing potency. These results suggest that E. umbellata extract possess potential antiamnesic effects and amongst the isolated compounds, compound I could be more effective anti-amnesic therapeutics. However, further studies are needed to identify the exact mechanism of action. Graphical abstract:

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12906-020-02942-3

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Total phenolic/flavonoids contents, anticholinesterase and antioxidant potential of extract/fractions and isolated compound of Elaeagnus umbellata Fruit. {(a) Total phenolic content expressed as gallic acid equivalents (mg GAE)/g dry plant sample; (b) Total flavonoid content expressed as quercetin equivalents (mg QE)/g dry plant sample; (c) %AChE and (d) %BChE inhibition potential of extract/fractions; (e) %AChE and (f) %BChE inhibition potential of isolated compounds; (g) DPPH and (h) ABTS free radical scavenging activity of isolated compounds}
Fig. 1 Total phenolic/flavonoids contents, anticholinesterase and antioxidant potential of extract/fractions and isolated compound of Elaeagnus umbellata Fruit. {(a) Total phenolic content expressed as gallic acid equivalents (mg GAE)/g dry plant sample; (b) Total flavonoid content expressed as quercetin equivalents (mg QE)/g dry plant sample; (c) %AChE and (d) %BChE inhibition potential of extract/fractions; (e) %AChE and (f) %BChE inhibition potential of isolated compounds; (g) DPPH and (h) ABTS free radical scavenging activity of isolated compounds}CC BY · PubMed Central
Fig. 2 Effect of CHF. Ext and isolated compound chlorogenic acid of Elaeagnus umbellata Thunb. on mice in the behavioural Y-maze test. {(a) number of arm entries (b) Same arm returns (c) alternate arm returns (d) % Spontaneous alteration performance were recorded in CHF. Ext (50, 100 and 200 mg/kg) groups versus scopolamine (Scop. 1 mg/kg) treated group; (e) number of arm entries (f) Same arm returns (g) alternate arm returns (h) % Spontaneous alteration performance were recorded in isolated compound chlorogenic acid (1, 3, 10 and 30 mg/kg) treated groups versus scopolamine (Scop. 1 mg/kg) treated group}
Fig. 2 Effect of CHF. Ext and isolated compound chlorogenic acid of Elaeagnus umbellata Thunb. on mice in the behavioural Y-maze test. {(a) number of arm entries (b) Same arm returns (c) alternate arm returns (d) % Spontaneous alteration performance were recorded in CHF. Ext (50, 100 and 200 mg/kg) groups versus scopolamine (Scop. 1 mg/kg) treated group; (e) number of arm entries (f) Same arm returns (g) alternate arm returns (h) % Spontaneous alteration performance were recorded in isolated compound chlorogenic acid (1, 3, 10 and 30 mg/kg) treated groups versus scopolamine (Scop. 1 mg/kg) treated group}CC BY · PubMed Central
Fig. 3 Effect of CHF. Ext and isolated compound (CGA) of E. umbellata Thunb. on mice in behavioural NORT {(a) Time spent in the sample phase (b) Time spent in the test phase (c) % Discrimination index were recorded in CHF. Ext (50, 100 and 200 mg/kg) treated groups versus scopolamine (Scop. 1 mg/kg) treated group and (d) Time spent in the sample phase (e) Time spent in the test phase (f) % Discrimination index were recorded in isolated compound chlorogenic acid (CGA: 1, 3, 10 and 30 mg/kg) treated groups versus scopolamine (Scop. 1 mg/kg) treated group for assessment of short-term memory in mice model in behavioral NORT; (g) Time spent in the sample phase (h) Time spent in the test phase (i) % Discrimination index were recorded in CHF. Ext (50, 100 and 200 mg/kg) treated groups versus scopolamine (Scop. 1 mg/kg) treated group and (j) Time spent in the sample phase (k) Time spent in the test phase (l) % Discrimination index were recorded for isolated compound chlorogenic acid (1, 3, 10 and 30 mg/kg) treated groups versus scopolamine (Scop. 1 mg/kg) treated group for assessment of long-term memory in mice model in behavioral NORT}
Fig. 3 Effect of CHF. Ext and isolated compound (CGA) of E. umbellata Thunb. on mice in behavioural NORT {(a) Time spent in the sample phase (b) Time spent in the test phase (c) % Discrimination index were recorded in CHF. Ext (50, 100 and 200 mg/kg) treated groups versus scopolamine (Scop. 1 mg/kg) treated group and (d) Time spent in the sample phase (e) Time spent in the test phase (f) % Discrimination index were recorded in isolated compound chlorogenic acid (CGA: 1, 3, 10 and 30 mg/kg) treated groups versus scopolamine (Scop. 1 mg/kg) treated group for assessment of short-term memory in mice model in behavioral NORT; (g) Time spent in the sample phase (h) Time spent in the test phase (i) % Discrimination index were recorded in CHF. Ext (50, 100 and 200 mg/kg) treated groups versus scopolamine (Scop. 1 mg/kg) treated group and (j) Time spent in the sample phase (k) Time spent in the test phase (l) % Discrimination index were recorded for isolated compound chlorogenic acid (1, 3, 10 and 30 mg/kg) treated groups versus scopolamine (Scop. 1 mg/kg) treated group for assessment of long-term memory in mice model in behavioral NORT}CC BY · PubMed Central
Fig. 4 Ex-vivo % AChE and BChE activity in the frontal cortex and hippocampus of different animal groups {(a & b) Different animal groups Scopolamine (Scop. 1 mg/kg) treated group, Donepezil (DZP) treated group, Normal control group, CGA & CHF treated group were used in behavioral Y maze test to assess AChE and BChE activity; while (c & d) has shown AChE and BChE activity in NORT}
Fig. 4 Ex-vivo % AChE and BChE activity in the frontal cortex and hippocampus of different animal groups {(a & b) Different animal groups Scopolamine (Scop. 1 mg/kg) treated group, Donepezil (DZP) treated group, Normal control group, CGA & CHF treated group were used in behavioral Y maze test to assess AChE and BChE activity; while (c & d) has shown AChE and BChE activity in NORT}CC BY · PubMed Central
Fig. 5 Ex-Vivo %DPPH free radical scavenging effects in frontal cortex and hippocampus of different animal groups {(a & b) Different animal groups (Scopolamine (Scop. 1 mg/kg) treated group, Donepezil (DZP) treated group, Normal control group, CGA & CHF treated group) were used in behavioral Y maze test to assess %DPPH inhibition potential in frontal cortex and hippocampus of different animal groups; while (c & d) has shown %DPPH inhibition in NORT}
Fig. 5 Ex-Vivo %DPPH free radical scavenging effects in frontal cortex and hippocampus of different animal groups {(a & b) Different animal groups (Scopolamine (Scop. 1 mg/kg) treated group, Donepezil (DZP) treated group, Normal control group, CGA & CHF treated group) were used in behavioral Y maze test to assess %DPPH inhibition potential in frontal cortex and hippocampus of different animal groups; while (c & d) has shown %DPPH inhibition in NORT}CC BY · PubMed Central
Fig. 6 Molecular docking validation of compounds chlorogenic acid and ellagic acid against AChE & BChE {(a) Superimposed ribbon diagram for chlorogenic acid and donepezil (b) Stereo view of the docking posture of chlorogenic acid (green color stick model) in the binding pocket of AChE enzyme (c) 2D interactions of chlorogenic acid. d Stereo view of the docking posture of chlorogenic acid (purple color stick model) in the binding pocket of BChE enzyme (e) 2D interactions of chlorogenic acid (f) Superimposed ribbon diagram for ellagic acid and donepezil (g) Stereo view of the docking posture of ellagic acid (green color stick model) in the binding pocket of AChE enzyme (h) 2D interactions of ellagic acid}
Fig. 6 Molecular docking validation of compounds chlorogenic acid and ellagic acid against AChE & BChE {(a) Superimposed ribbon diagram for chlorogenic acid and donepezil (b) Stereo view of the docking posture of chlorogenic acid (green color stick model) in the binding pocket of AChE enzyme (c) 2D interactions of chlorogenic acid. d Stereo view of the docking posture of chlorogenic acid (purple color stick model) in the binding pocket of BChE enzyme (e) 2D interactions of chlorogenic acid (f) Superimposed ribbon diagram for ellagic acid and donepezil (g) Stereo view of the docking posture of ellagic acid (green color stick model) in the binding pocket of AChE enzyme (h) 2D interactions of ellagic acid}CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. Dassault Systemes BIOVIA. BIOVIA discovery studio visualizer, release 17: 2.0. 16349. Dassault Systemes: San Diego; 2016.

Cited by

See all 60

Metadata

Authors
Nazir, N., Zahoor, M., Nisar, M., Karim, N., Latif, A., Ahmad, S., & Uddin, Z.
Affiliations
  • University of Malakand (PK)
  • Sarhad University of Science and Information Technology (PK)
  • COMSATS University Islamabad (PK)
Corresponding author
Nazir, Nausheen
Venue
BMC Complementary Medicine and Therapies
Published
2020-05-12
Volume
20
Issue
1
Pages
143-143
ISSN
2662-7671 (ISSN-L)
OpenAlex
W3026517281
Cited by
57
References
49
Citations by year
2026: 4 · 2025: 6 · 2024: 15 · 2023: 6 · 2022: 9 · 2021: 10 · 2020: 6
FWCI
8.59
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Complementary Medicine and Therapies (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Higher Education Commision, Pakistan
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
  • Health Sciences › Medicine › Complementary and alternative medicine › Ginkgo biloba and Cashew Applications
Keywords
neuroprotection, anti-amnesic effect, scopolamine-induced amnesia, learning and memory, chlorogenic acid, anticholinesterase activity, antioxidant activity, Y-maze, novel object recognition, phenolic and flavonoid content, molecular docking, medicinal plant extracts
MeSH terms
Amnesia, Animals, Antioxidants, Cholinesterase Inhibitors, Disease Models, Animal, Pakistan, Plant Extracts, Scopolamine, Neuroprotective Agents, Elaeagnaceae, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of neuroprotective and anti-amnesic effects of Elaeagnus umbellata Thunb. On scopolamine-induced memory impairment in mice. https://app.cochat.ai/papers/10.1186/s12906-020-02942-3
The paper
Nazir, N., Zahoor, M., Nisar, M., Karim, N., Latif, A., Ahmad, S., & Uddin, Z. (2020). Evaluation of neuroprotective and anti-amnesic effects of Elaeagnus umbellata Thunb. On scopolamine-induced memory impairment in mice. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-020-02942-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.